How do you decide if a fractional CRO is right for a Series A company when sales and marketing are misaligned?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

The Series A Buying Dynamics When Sales and Marketing Are Misaligned

The buying committee at a Series A company facing sales-marketing misalignment is deceptively small but fractured. It typically includes the CEO (who owns the revenue number and often still carries a bag), the VP of Sales (or head of sales, often the first sales hire who is now managing 3-7 reps), and the Head of Marketing (often a first-time marketing leader who came from a demand gen or product marketing background). The board observer or lead investor may be informally involved, but they rarely vote - they signal concern. The CEO is the ultimate decision-maker on the fractional CRO hire, but the budget approval process is unusual: it comes from the same operating budget that funds the sales team's variable comp and marketing's ad spend, so every dollar spent on the fractional CRO is a dollar not spent on a new SDR or a trade show. This creates tension because the CEO must justify a six-figure fractional engagement (typically $15k-$25k per month for 3-6 months) against visible frontline investments.

The buyer evaluates the fractional CRO on two axes: first, can they diagnose the misalignment in under two weeks without triggering a political firestorm; second, do they have a repeatable playbook for unifying pipeline definitions, lead handoffs, and revenue reporting that the existing team cannot build themselves. The deal shape here is not a product sale - it's a service engagement with a defined scope, often structured as a monthly retainer with a 30-day termination clause. Stalls happen when the CEO cannot decide whether the misalignment is a people problem (fire one of the two leaders) or a process problem (hire the fractional CRO). The most common stall is the CEO asking for a "trial month" to see if the fractional CRO can produce quick wins, which is a red flag that the CEO is not ready to empower the role with authority over both teams.

Budget approval is informal but rigorous: the CEO must be able to explain to the board why a fractional solution is better than a full-time CRO hire (which would cost $250k-$350k total comp plus equity) or doing nothing. The board typically approves if the fractional CRO can show a clear 90-day plan to reduce the sales cycle by 20% or increase marketing-influenced pipeline by 30%, because those metrics are directly tied to the Series A company's need to hit the next funding milestone. If the company has already burned through a VP of Sales or a CMO in the past 12 months, the budget gets approved faster because the cost of another failed full-time hire is higher than the fractional engagement.

The Sales-Cycle Implications of Series A Misalignment

When sales and marketing are misaligned at a Series A company, the sales cycle for the company's own product gets distorted in a specific way: the marketing team generates leads that sales ignores because they are not SQL-qualified by the sales team's unstated criteria, and sales blames marketing for low conversion rates while marketing blames sales for not following up. This creates a phantom pipeline - deals that exist in the CRM but have zero chance of closing because they were never properly qualified. The actual sales cycle length for the company's product is typically 30-60 days for SMB deals or 60-90 days for mid-market, but the misalignment makes it feel longer because sales reps spend 30% of their time arguing about lead quality instead of selling.

The motion this forces is a reactive, firefighting cadence. The CEO ends up mediating weekly disputes between sales and marketing, which pulls them away from board relations, product strategy, and fundraising. The sales team operates on a "shoot first, ask questions later" mentality - they will take any lead that looks like a company name and try to close it, which inflates the pipeline but tanks close rates. Marketing, in response, starts generating more volume to compensate for low conversion, which makes the problem worse. The ramp for a new rep is artificially long because they cannot trust the marketing pipeline and must build their own prospecting lists from scratch, which defeats the purpose of having a marketing function at a Series A company.

Forecast behavior becomes unreliable. The VP of Sales will give the CEO a number based on "gut feel" because the CRM data is polluted by unqualified leads and deals that should have been disqualified. The marketing team cannot forecast pipeline contribution because they do not know which of their campaigns actually produce closed-won revenue - attribution is broken or nonexistent. The pipeline shape is a barbell: a few large deals that the CEO is personally involved in (often from the founder's network) and a long tail of tiny, unqualified leads that never convert. The middle of the funnel is empty because there is no structured nurture path for leads that are not ready to buy today.

The leaks are concentrated in three places. First, the lead-to-MQL handoff: marketing defines an MQL as someone who downloaded an ebook, but sales defines an MQL as someone who has a budget and a timeline. Second, the MQL-to-SQL conversion: sales does not have a consistent qualification framework (no BANT, MEDDIC, or similar), so they cherry-pick leads that look easy and ignore the rest. Third, the SQL-to-opportunity stage: even when a lead is qualified, the handoff between the SDR (if one exists) and the account executive is manual and slow, causing leads to go cold. At a Series A company, these leaks are fatal because the company cannot afford to waste leads - each one represents a significant investment of marketing spend or founder time.

What a Fractional CRO Looks Like at a Series A Company With Misalignment

The fractional CRO in this situation is not a generalist - they are a specialist in fixing broken go-to-market processes at early-stage companies. Their first 90 days follow a specific playbook. In week one, they shadow both sales and marketing teams, listening in on calls, reviewing CRM data, and mapping the current lead flow. They do not make any changes in week one. In week two, they present a "state of alignment" audit to the CEO and the two functional heads, showing exactly where leads are being dropped, where definitions diverge, and where the revenue reporting is inaccurate. This audit is the key deliverable because it creates a shared fact base that neither side can argue with.

In weeks three through six, they implement three non-negotiable changes: a unified lead definition (agreed upon by both teams and written into the CRM), a weekly pipeline review meeting where sales and marketing jointly review every deal in the pipeline above a certain stage, and a shared revenue dashboard that both teams use to report to the CEO. The fractional CRO does not take over sales or marketing management - they own the process between the two functions. They advise the VP of Sales on forecast methodology and advise the Head of Marketing on campaign attribution, but they do not fire or hire anyone in the first 60 days unless there is clear evidence of incompetence or bad faith.

Their operating cadence is structured and visible. They hold a 30-minute daily standup with the sales and marketing leads (no one else) to track the top three pipeline actions for the day. They hold a 90-minute weekly pipeline review with the full revenue team. They meet with the CEO for 30 minutes twice a week to report progress and flag any personnel issues. They do not attend board meetings unless specifically asked, and they do not present to investors - that is the CEO's job. The fractional CRO's value is in making the existing team more effective, not in being the public face of revenue.

The signals to convert to full-time are specific. If, after 90 days, the misalignment is resolved (pipeline definitions are consistent, weekly reviews are happening without CEO mediation, and forecast accuracy has improved by at least 15 percentage points), but the company still needs a permanent executive to scale the revenue function beyond the current team, then converting to full-time makes sense. If the misalignment is resolved and the VP of Sales and Head of Marketing can now work together independently, the fractional CRO should exit and leave the CEO to manage the revenue function directly or promote from within. If the misalignment is not resolved after 90 days, the fractional CRO should recommend replacing one or both functional leads before considering a permanent CRO hire - because a full-time CRO cannot succeed with broken team members.

The fractional CRO owns the revenue process, not the revenue number. They are accountable for installing the systems that enable accurate forecasting and pipeline management, but they do not carry a quota. This is a critical distinction at a Series A company because the CEO often wants the fractional CRO to personally close deals or fix the sales team's performance, which is not the role. The fractional CRO's success metric is whether the sales and marketing teams can operate without CEO intervention after the engagement ends.

The Economics of a Fractional CRO at Series A

The cost structure for a fractional CRO at a Series A company is typically a monthly retainer of $15,000 to $25,000 for a 3-6 month engagement, with a one-time setup fee of $5,000 to $10,000 for the initial audit and process design. This is roughly one-third to one-half the monthly cost of a full-time CRO (who would command $20,000-$30,000 per month in salary plus benefits and equity). The fractional model is cheaper in the short term but more expensive per hour - the value is in the speed of deployment and the lack of long-term commitment.

The company should expect to pay for the fractional CRO from the sales and marketing budget, not from a separate "executive" line item. This forces discipline: the CEO must be willing to reduce spending on something else (a trade show, a new tool, a headcount) to fund the engagement. If the company cannot find $90,000-$150,000 in the annual go-to-market budget for a fractional CRO, the misalignment is probably not the biggest problem - the problem is that the company is underinvested in revenue operations overall.

The ROI calculation is straightforward: if the fractional CRO can reduce the sales cycle by 20% (from 60 days to 48 days) and increase marketing-influenced pipeline by 30% (from $1M to $1.3M per quarter), the incremental revenue from those improvements should pay for the engagement within two quarters. But the board and the CEO must be patient - the first 60 days are about process installation, not revenue acceleration. The revenue lift comes in months three through six.

The Warning Signs That a Fractional CRO Is Not the Right Solution

A fractional CRO is not the right solution for a Series A company with sales-marketing misalignment if the CEO is unwilling to give the fractional CRO authority over both functions. If the CEO wants the fractional CRO to "advise" but not "direct," the engagement will fail because neither sales nor marketing will change their behavior. The fractional CRO needs the explicit mandate to set pipeline definitions, enforce meeting cadences, and adjust compensation if necessary. Without this mandate, the misalignment persists.

Another warning sign is if the company has already tried and failed with a fractional CRO before. This suggests the problem is not process but personnel - one or both of the functional leads are not capable of executing the new processes, and a fractional CRO cannot fix a people problem. In this case, the CEO should replace the underperforming leader before hiring any CRO, fractional or full-time.

A third warning sign is if the company's Series A round is less than $5 million and the burn rate is high. A fractional CRO engagement costs $90,000-$150,000, which is 2-3% of the round. If the company is burning through cash and needs to hit a specific revenue milestone in the next 6-9 months to raise a Series B, the fractional CRO may be a distraction. The CEO should instead focus on personally closing deals and hiring a strong VP of Sales who can also handle marketing alignment.

The Exit Strategy for the Fractional CRO

Every fractional CRO engagement at a Series A company should have a predefined exit strategy written into the contract. The most common exit is a clean handoff after 4-6 months, where the fractional CRO documents all processes, trains the VP of Sales and Head of Marketing on how to maintain the alignment, and provides a 30-day transition period with reduced hours. The company then operates with a "revenue ops manager" or a senior IC who manages the pipeline without an executive title.

The second exit is a conversion to full-time CRO, which happens in about 30% of cases. This requires the fractional CRO to prove they can scale beyond process installation into strategic revenue growth - they must show they can hire, coach, and lead a growing team. The conversion typically happens at month four or five, and the compensation package is negotiated based on the company's current ARR and growth rate.

The third exit is an early termination, which happens in about 10% of cases. This occurs when the CEO realizes the misalignment is a symptom of a deeper problem - the product is not ready for scale, the market is too small, or the team is fundamentally dysfunctional. The fractional CRO should have a 30-day termination clause to allow a clean break without acrimony. The key is that the fractional CRO does not become a permanent crutch - the engagement must have a defined end date from day one.

FAQ

A question: How do I know if my Series A company's sales-marketing misalignment is bad enough to justify a fractional CRO? If the CEO is spending more than 5 hours per week mediating disputes between sales and marketing, or if the forecast accuracy is below 50% for two consecutive quarters, the misalignment is costing more than the fractional CRO engagement. The simplest test: ask your VP of Sales and Head of Marketing to independently define what a "qualified lead" is. If their definitions differ by more than two criteria, you need a fractional CRO.

A question: Can a fractional CRO fix misalignment if the VP of Sales is the founder's brother-in-law? No. A fractional CRO cannot fix nepotism or structural conflicts of interest. If one of the two functional leads has a personal relationship with the CEO that prevents objective feedback, the fractional CRO will be ignored or undermined. The CEO must be willing to hold both leaders accountable to the same process, regardless of personal ties.

A question: What if the fractional CRO wants to replace both the VP of Sales and the Head of Marketing? That is a legitimate recommendation if the misalignment is caused by incompetence, not process gaps. However, a fractional CRO should not execute personnel changes themselves - they should present the evidence to the CEO and let the CEO make the decision. A good fractional CRO will say, "These two leaders cannot execute the process I am installing. Here are the specific gaps. You decide what to do."

A question: How do I measure the success of a fractional CRO engagement at my Series A company? Use three metrics: pipeline definition consistency (are sales and marketing using the same lead stages and criteria?), forecast accuracy (has it improved by at least 15 percentage points?), and CEO time spent on revenue disputes (should drop from 5+ hours per week to less than 1 hour). If all three improve by month three, the engagement is working. If only one or two improve, extend the engagement by 60 days and re-evaluate.

Sources